SCHEMBL19080161

SCHEMBL19080161

c1ccc2cc3c(cc2c1)oc1cc2cc(-c4ccc(-c5c6ccccc6c(-c6ccc7oc8ccccc8c7c6)c6ccccc56)cc4)ccc2cc13

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 3/20 0.41
AHR P35869 2/20 0.41
NPC1 O15118 2/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
PLA2G2A P14555 2/20 0.39
PLA2G4A P47712 2/20 0.39
HCRTR1 O43613 1/20 0.38
PGR P06401 1/20 0.37
ESR1 P03372 2/20 0.36
ESR2 Q92731 2/20 0.36
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24341315 0.99 CASP3 (0.40) MAPTKDM4EHPGDAHRNPC1
SCHEMBL19076589 0.97 MAPT (0.41) MAPTKDM4EHPGDAHRNPC1
SCHEMBL22063115 0.96 AHR (0.41) MAPTKDM4EHPGDAHRNPC1
SCHEMBL19109851 0.96 MAPT (0.41) MAPTKDM4EHPGDAHRNPC1
SCHEMBL16067679 0.96 MAPT (0.44) MAPTKDM4EHPGDAHRNPC1
SCHEMBL19109802 0.94 PLA2G2A (0.42) MAPTKDM4EHPGDAHRNPC1
SCHEMBL24341532 0.94 PLA2G2A (0.45) MAPTKDM4EHPGDAHRNPC1
SCHEMBL19076375 0.94 AHR (0.41) MAPTKDM4EHPGDAHRNPC1
SCHEMBL19109803 0.94 PLA2G2A (0.42) MAPTKDM4EHPGDAHRNPC1
SCHEMBL24341275 0.94 MAPT (0.42) MAPTKDM4EHPGDAHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 MAPT 1538/4885KDM4E 3545/4885HPGD 1696/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 MAPT 1538/4885KDM4E 3545/4885HPGD 1696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.